References
- T. Hirobe, Keratinocytes regulate the function of melanocytes, Dermatologica Sinica, 32(4), 200 (2014). https://doi.org/10.1016/j.dsi.2014.05.002
- A. Hachiya, A. Kobayashi, A. Ohuchi, Y. Takema, and G. Imokawa, The paracrine role of stem cell factor/c-kit signaling in the activation of human melanocytes in ultraviolet-B-induced pigmentation, J. Invest. Dermatol., 116(4), 578 (2001). https://doi.org/10.1046/j.1523-1747.2001.01290.x
- T. Hirobe, K. Hasegawa, R. Furuya, R. Fujiwara, and K. Sato, Effects of fibroblast-derived factors on the proliferation and differentiation of human melanocytes in culture, J. Dermatol. Sci, 71(1), 45 (2013). https://doi.org/10.1016/j.jdermsci.2013.03.012
- E. Schauer, F. Trautinger, A. Kock, A. Schwarz, R. Bhardwaj, M. Simon, J.C. Ansel, T. Schwarz, and T. A. Luger, Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes, J. Clin. Invest., 93(5), 2258 (1994). https://doi.org/10.1172/JCI117224
- A. K. Chakraborty, Y. Funasaka, A. Slominski, G. Ermak, J. Hwang, J. M. Pawelek, and M. Ichihashi, Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B, Biochim. Biophys. Acta, 1313(2), 130 (1996). https://doi.org/10.1016/0167-4889(96)00063-8
- K. Wakamatsu, A. Graham, D. Cook, and A. J. Thody, Characterisation of ACTH peptides in human skin and their activation of the melanocortin-1 receptor, Pigment Cell Res., 10(5), 288 (1997). https://doi.org/10.1111/j.1600-0749.1997.tb00688.x
- G. Imokawa, Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders, Pigment Cell Res., 17(2), 96 (2004). https://doi.org/10.1111/j.1600-0749.2003.00126.x
- A. Chakraborty, A. Slominski, G. Ermak, J. Hwang, and J. Pawelek, Ultraviolet B and melanocyte-stimulating hormone (MSH) stimulate mRNA production for alpha MSH receptors and proopiomelanocortin-derived peptides in mouse melanoma cells and transformed keratinocytes, J. Invest. Dermatol., 105(5), 655 (1995). https://doi.org/10.1111/1523-1747.ep12324134
- M. Khaled, L. Larribere, K. Bille, E. Aberdam, J. P. Ortonne, R. Ballotti, and C. Bertolotto, Glycogen synthase kinase 3beta is activated by cAMP and plays an active role in the regulation of melanogenesis, J. Biol. Chem., 277(37), 33690 (2002). https://doi.org/10.1074/jbc.M202939200
- Y. M. Kim, S. E. Cho, and Y. K. Seo, The activation of melanogenesis by p-CREB and MITF signaling with extremely low-frequency electromagnetic fields on B16F10 melanoma, Life Sci., 162, 25 (2016). https://doi.org/10.1016/j.lfs.2016.08.015
- K. Kameyama, C. Sakai, S. Kuge, S. Nishiyama, Y. Tomita, S. Ito, K. Wakamatsu, and V. J. Hearing, The expression of tyrosinase, tyrosinase-related proteins 1 and 2 (TRP1 and TRP2), the silver protein, and a melanogenic inhibitor in human melanoma cells of differing melanogenic activities, Pigment Cell Res., 8(2), 97 (1995). https://doi.org/10.1111/j.1600-0749.1995.tb00648.x
- G. Raposo, and M. S. Marks, Melanosomes-dark organelles enlighten endosomal membrane transport, Nat. Rev. Mol. Cell Biol., 8(10), 786 (2007). https://doi.org/10.1038/nrm2258
- L. D'Alba and M. D. Shawkey, Melanosomes: biogenesis, properties, and evolution of an ancient organelle, Physiol. Rev., 99(1), 1 (2019). https://doi.org/10.1152/physrev.00059.2017
- M. Van Gele, B. Geusens, A. M. Schmitt, L. Aguilar, and J. Lambert, Knockdown of myosin Va isoforms by RNAi as a tool to block melanosome transport in primary human melanocytes, J. Invest. Dermatol., 128(10), 2474 (2008). https://doi.org/10.1038/jid.2008.100
- N. Ohbayashi and M. Fukuda, Role of Rab family GTPases and their effectors in melanosomal logistics, J. Biochem., 151(4), 343 (2012). https://doi.org/10.1093/jb/mvs009
- J. I. Park, H. Y. Lee, J. E. Lee, C. H. Myung, and J. S. Hwang, Inhibitory effect of 2-methyl-naphtho [1,2,3-de]quinolin-8-one on melanosome transport and skin pigmentation, Sci Rep, 6, 29189 (2016). https://doi.org/10.1038/srep29189
- G. Cardinali, S. Ceccarelli, D. Kovacs, N. Aspite, L. V. Lotti, M. R. Torrisi, and M. Picardo, Keratinocyte growth factor promotes melanosome transfer to keratinocytes, J. Invest. Dermatol., 125(6), 1190 (2005). https://doi.org/10.1111/j.0022-202X.2005.23929.x
- J. H. Epstein, Photocarcinogenesis, skin cancer, and aging, J. Am. Acad. Dermatol., 9(4), 4 87 ( 1983 ). https://doi.org/10.1016/S0190-9622(83)70160-X
- R. Speeckaert, M. Van Gele, M. M. Speeckaert, J. Lambert, and N. van Geel, The biology of hyperpigmentation syndromes, Pigment Cell Melanoma Res, 27(4), 512 (2014). https://doi.org/10.1111/pcmr.12235
- M. B. C. Maymone, H. H. Neamah, E. A. Secemsky, and N. A. Vashi, Correlating the dermatology life quality index and skin discoloration impact evaluation questionnaire tools in disorders of hyperpigmentation, J. Dermatol., 45(3), 361 (2018). https://doi.org/10.1111/1346-8138.14172
- T. Pillaiyar, M. Manickam, and V. Namasivayam, Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors, J Enzyme Inhib Med Chem, 32(1), 403 (2017). https://doi.org/10.1080/14756366.2016.1256882
- M. L. W. Juhasz and M. K. Levin, The role of systemic treatments for skin lightening, J Cosmet Dermatol, 17(6), 1144 (2018). https://doi.org/10.1111/jocd.12747
- L. Zhang and T. J. Falla, Cosmeceuticals and peptides, Clin. Dermatol., 27(5), 485 (2009). https://doi.org/10.1016/j.clindermatol.2009.05.013
- B. Reddy, T. Jow, and B. M. Hantash, Bioactive oligopeptides in dermatology: Part I, Exp. Dermatol., 21(8), 563 (2012). https://doi.org/10.1111/j.1600-0625.2012.01528.x
- B. Reddy, T. Jow, and B. M. Hantash, Bioactive oligopeptides in dermatology: Part II, Exp. Dermatol., 21(8), 569 (2012). https://doi.org/10.1111/j.1600-0625.2012.01527.x
- V. V. Pai, P. Bhandari, and P. Shukla, Topical peptides as cosmeceuticals, Indian J Dermatol Venereol Leprol, 83(1), 9 (2017). https://doi.org/10.4103/0378-6323.186500
- S. Marepally, C. H. Boakye, P. P. Shah, J.R . Etukala, A. Vemuri, and M. Singh, Design, synthesis of novel lipids as chemical permeation enhancers and development of nanoparticle system for transdermal drug delivery, PLoS ONE, 8(12), e82581 (2013). https://doi.org/10.1371/journal.pone.0082581
- H. Kalluri, and A. K. Banga, Transdermal delivery of proteins, AAPS PharmSciTech, 12(1), 431 (2011). https://doi.org/10.1208/s12249-011-9601-6
- A. A. Strömstedt, M. Pasupuleti, A. Schmidtchen, and M. Malmsten, Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37, Antimicrob. Agents Chemother., 53(2), 593 (2009). https://doi.org/10.1128/AAC.00477-08